Save on XALATAN and receive the Xal-Ease™ applicator when you Sign Up for Vision Matters™
What Does Glaucoma Look Like?
Glaucoma progresses differently for each person. It depends on the type of glaucoma, how early it's detected, and whether or not it is being treated. Normally, the damage progresses over a number of years. But sometimes it moves much more quickly.
Unfortunately, damage caused by glaucoma can't be reversed. For this reason, it's important to see your eye doctor on a regular basis. Through early detection, you and your doctor can help save your vision.
The Vision Simulator
This simulator was made to show people how glaucoma can change vision over time.
To begin, click on the button and drag it to the right, or just click different points on the white line. You will see a simulation of how glaucoma progresses if left untreated.
Vision Simulator
This video requires a Flash player and JavaScript. If you don't have the latest version, you can download the player free of charge.
XALATAN Video Library
Patients and experts talk about high eye pressure, XALATAN, and Xal-Ease™. Watch now
Talking With Your Doctor
Learn how to talk to your eye doctor about high eye pressure and XALATAN. Get it now
Indication
XALATAN is for the treatment of high eye pressure/intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.
Important Safety Information
Like all medicines, XALATAN can have side effects. These side effects are usually mild and tolerable and may include blurred vision, burning and stinging, eye redness, the feeling of something in the eye, eye itching, increased pigmentation (darkening) of eye color, or irritation of the clear front surface of the eye.
XALATAN may slowly cause darkening of the eye color due to increased brown color, darkening of the eyelid and eyelashes, and increased growth and thickness of eyelashes. Color changes can increase as long as XALATAN is administered and eye color changes are likely to be permanent.
The recommended dosage is one drop (1.5 µg) in the affected eye(s) once daily in the evening. If one dose is missed, treatment should continue with the next dose as normal.
There have been reports of bacterial keratitis associated with the use of multiple-dose containers of topical ophthalmic products.
The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.
Pfizer is a licensee of the TRUSTe Privacy Program.© 2010 Pfizer Inc. All rights reserved.
XLU00691F